175 related articles for article (PubMed ID: 16515618)
21. [Burkitt's lymphoma presenting as ovarian tumor].
Dudnyikova A; Tóth E; Deák B; Pete I
Magy Onkol; 2012 Dec; 56(4):282-6. PubMed ID: 23236599
[TBL] [Abstract][Full Text] [Related]
22. Burkitt's lymphoma presenting as ovarian torsion.
Taylor JS; Frey MK; Fatemi D; Robinson S
Am J Obstet Gynecol; 2012 Aug; 207(2):e4-6. PubMed ID: 22742781
[TBL] [Abstract][Full Text] [Related]
23. A Case of Burkitt's Lymphoma Involving Both Breasts.
Ogawa T; Mizutani M; Yabana T; Miyahara S; Murabayashi K
Breast Cancer; 2005; 12(3):234-7. PubMed ID: 16110296
[TBL] [Abstract][Full Text] [Related]
24. Primary Burkitt's lymphoma of the ovary.
Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
[No Abstract] [Full Text] [Related]
25. Primary gastric Burkitt's lymphoma presenting with c-myc gene rearrangement.
Andoh A; Takaya H; Bamba M; Sakumoto H; Inoue T; Tujikawa T; Koyama S; Fujiyama Y; Bamba T
J Gastroenterol; 1998 Oct; 33(5):710-5. PubMed ID: 9773936
[TBL] [Abstract][Full Text] [Related]
26. [Case of metachronous mucosa-associated lymphoid tissue (MALT) lymphoma originated from a distinct B-cell clone].
Shimizu H; Takiguchi Y; Kobayashi H; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Hiroshima K; Kuriyama T
Nihon Kokyuki Gakkai Zasshi; 2008 Sep; 46(9):759-63. PubMed ID: 18939422
[TBL] [Abstract][Full Text] [Related]
27. The effects of rituximab treatment during pregnancy on a neonate.
Friedrichs B; Tiemann M; Salwender H; Verpoort K; Wenger MK; Schmitz N
Haematologica; 2006 Oct; 91(10):1426-7. PubMed ID: 16963391
[TBL] [Abstract][Full Text] [Related]
28. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
29. Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype.
Sun J; Zhang J; Ling Q; Luo Y; Wu S; Liang Z; Zhong D; Zeng X
Virchows Arch; 2015 Jan; 466(1):93-100. PubMed ID: 25403088
[TBL] [Abstract][Full Text] [Related]
30. Burkitt's lymphoma of the ovary.
Mukhtar AU; Mugerwa B
Cent Afr J Med; 1999 Apr; 45(4):104-5. PubMed ID: 10746392
[TBL] [Abstract][Full Text] [Related]
31. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
[No Abstract] [Full Text] [Related]
32. Diffuse aggressive lymphoma.
Fisher RI; Miller TP; O'Connor OA
Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
[TBL] [Abstract][Full Text] [Related]
33. 24-year-old female with amenorhea: bilateral primary ovarian Burkitt lymphoma.
Baloglu H; Turken O; Tutuncu L; Kizilkaya E
Gynecol Oncol; 2003 Nov; 91(2):449-51. PubMed ID: 14599883
[TBL] [Abstract][Full Text] [Related]
34. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
36. Biology and treatment of Burkitt's lymphoma.
Yustein JT; Dang CV
Curr Opin Hematol; 2007 Jul; 14(4):375-81. PubMed ID: 17534164
[TBL] [Abstract][Full Text] [Related]
37. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.
Howard OM; Gribben JG; Neuberg DS; Grossbard M; Poor C; Janicek MJ; Shipp MA
J Clin Oncol; 2002 Mar; 20(5):1288-94. PubMed ID: 11870171
[TBL] [Abstract][Full Text] [Related]
38. Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.
Italiano A; Peyrade F; Soler C; Cardot N; Thyss A
J Chemother; 2007 Apr; 19(2):236-8. PubMed ID: 17434838
[No Abstract] [Full Text] [Related]
39. [Case of malignant lymphoma arising from the posterior mediastinum, with pleural effusion].
Nagashima O; Takahashi K; Sato K; Suzuki T; Fukuchi Y; Isobe Y; Oshimi K
Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):772-6. PubMed ID: 15455953
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
